BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19585675)

  • 1. IgE myeloma with elevated level of serum CA125.
    Wang ML; Huang Q; Yang TX
    J Zhejiang Univ Sci B; 2009 Jul; 10(7):559-62. PubMed ID: 19585675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.
    Hayes MJ; Carey JL; Krauss JC; Hedstrom DL; Gulbranson RL; Keren DF
    Eur J Haematol; 2007 Apr; 78(4):353-7. PubMed ID: 17378894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new case of IgE myeloma.
    Alexander RL; Roodman ST; Petruska PJ; Tsai CC; Janney CG
    Clin Chem; 1992 Nov; 38(11):2328-32. PubMed ID: 1424132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE multiple myeloma.
    Macro M; André I; Comby E; Chèze S; Chapon F; Ballet JJ; Reman O; Leporrier M; Troussard X
    Leuk Lymphoma; 1999 Feb; 32(5-6):597-603. PubMed ID: 10048434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An IgE multiple myeloma: contradictory findings in clinical laboratory testing.
    Altinier S; Barberio G; Varagnolo M; Zaninotto M; Furlan A; Caberlotto L; Plebani M
    Clin Chim Acta; 2013 Oct; 425():114-6. PubMed ID: 23872298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
    Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum CA125 levels in plasma cell dyscrasias.
    Iwasaki T; Hamano T; Aizawa K; Kobayashi K; Kakishita E
    Acta Haematol; 1997; 98(2):104-8. PubMed ID: 9286307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgE myeloma: a case presentation and a review of the literature.
    Kairemo KJ; Lindberg M; Prytz M
    Scand J Clin Lab Invest; 1999 Oct; 59(6):451-6. PubMed ID: 10612556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [IgE myeloma. Laboratory typing difficulties].
    Bovone NS; Fuente MC; Gastiazoro AM; Alfonso G; Freitas MJ
    Medicina (B Aires); 2014; 74(6):472-3. PubMed ID: 25555008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new case of IgE myeloma.
    Invernizzi F; Monti G; Caviglia AG; Meroni P; Zanussi C
    Acta Haematol; 1991; 85(1):41-4. PubMed ID: 2011930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin E (IgE) multiple myeloma: a case report and review of the literature.
    Endo T; Okumura H; Kikuchi K; Munakata J; Otake M; Nomura T; Asakawa H
    Am J Med; 1981 May; 70(5):1127-32. PubMed ID: 7015852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.
    Sun J; Cui XW; Li YS; Wang SY; Yin Q; Wang XN; Gu L
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7276-7283. PubMed ID: 32706065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
    Wu CK; Yang AH; Lai HC; Lin BS
    BMC Nephrol; 2017 May; 18(1):170. PubMed ID: 28545410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expanding spectrum of clinical and laboratory features of IgE myeloma. (Report of a case and review of the literature).
    Dammacco F; Miglietta A; Tribalto M; Mandelli F; Bonomo L
    Ric Clin Lab; 1980; 10(4):583-90. PubMed ID: 7209293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The roles of serum free light chain ratio in the diagnosis and prognosis of newly diagnosed multiple myeloma].
    Wang PF; Xu Y; Yan S; Yao Y; Zheng HF; Ma L; Jin S; Xu Y; Gong FR; Zhou JZ; Chang HR; Fu CC
    Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):377-82. PubMed ID: 27210871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new case of IgE multiple myeloma with review of literature.
    Vignon G; Cognée AS; Carrere F; Masson I; Borde F; Augereau PF; Aucher P; Lellouche F
    Ann Biol Clin (Paris); 2017 Aug; 75(4):442-444. PubMed ID: 28751289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare case of the IgE prozone phenomenon in IgE multiple myeloma.
    Chae H; Kim H; Choi A; Oh EJ; Min CK
    Clin Biochem; 2022 Jun; 104():59-61. PubMed ID: 35131261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prozone effect of serum IgE levels in a case of plasma cell leukemia.
    Talamo G; Castellani W; Dolloff NG
    J Hematol Oncol; 2010 Sep; 3():32. PubMed ID: 20828419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations for early identification of damage to the skeleton by malignant processes, and for early diagnosis of multiple myeloma].
    Adam Z; Bednarík J; Neubauer J; Chaloupka R; Fojtík Z; Vanícek J; Pour L; Cermákova Z; Scudla V; Maisnar V; Straub J; Schützová M; Gregora E; Weinreb M; Stuchlíková K; Stanícek J; Hájek R; Krejcí M; Vorlícek J;
    Vnitr Lek; 2006 Nov; 52 Suppl 2():9, 11-31. PubMed ID: 18175427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple myeloma (IgG-kappa) infiltrating central nervous system, lymph nodes, liver, and kidneys, and with elevation of IgE].
    Toyota S; Nakamura N; Dan K
    Rinsho Ketsueki; 2004 May; 45(5):408-10. PubMed ID: 15199753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.